Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
TheraVet Optimizes its Commercial Strategy in France with a New Distribution Agreement with Elvetis
TheraVet, a pioneering biotechnology company in the treatment of bone and joint diseases in pets, […]
HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery
Shanghai Stock Exchange-listed company HitGen has announced that it has entered into a research agreement […]
Phanes Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate PT199 in Combination with Tislelizumab
Phanes Therapeutics, a clinical-stage biotech company focused on innovative drug discovery and development in oncology, […]
Vistin Pharma Enters into a Long-term Renewable Energy Supply Agreement with Statkraft
Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) announces that it has entered into a long-term […]
GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identification
GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, is partnering […]
Touchlight and Odimma Therapeutics Announce Clinical Material Supply Agreement to Develop Personalised Cancer Therapy Utilising Doggybone DNA
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, has announced a […]
PacBio and Boston Children's Hospital Collaborate to Investigate Novel Variants Inaccessible by Short-Read Sequencing
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, has announced its HiFi sequencing […]
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
AbbVie and HotSpot Therapeutics, a biotechnology company pioneering the discovery and development of small molecule […]
Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy
Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative […]
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
TherapeuticsMD, an innovative, leading women’s healthcare company, today announced that it has entered into definitive […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more